TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

Zom, G.G.; Welters, M.J.P.; Loof, N.M.; Goedemans, R.; Lougheed, S.; Valentijn, R.R.P.M.; ... ; Burg, S.H. van der (2016)

Article / Letter to editor

• Toll-like receptor ligand
• conjugate
• synthetic long peptide
• cancer vaccine
• cervical cancer

• All authors: Zom, G.G.; Welters, M.J.P.; Loof, N.M.; Goedemans, R.; Lougheed, S.; Valentijn, R.R.P.M.; Zandvliet, M.L.; Meeuwenoord, N.J.; Melief, C.J.M.; Gruijl, T.D. de; Marel, G.A. van der; Filippov, D.V.; Ossendorp, F.; Burg, S.H. van der
• Date: 2016-10-11
• Journal: Oncotarget
• Volume: 7
• Issue: 41
• Pages: 67087 - 67100
• DOI: doi:10.18632/oncotarget.11512